Could Mesothelioma Chemotherapy Ever Be Obsolete?
Oncologist Dr. Arek Dudek at Regions Hospital Cancer Care Center in St. Paul, Minnesota, believes his clinical trial involving a novel immunotherapy combination could change the way doctors treat pleural mesothelioma. Dudek is opening the only Phase II trial evaluating the combination of nivalumab (Opdivo) and ramucirumab (Cyramza) for previously treated mesothelioma patients. “This strategy – if successful, like we think it will be – could make treatment with chemotherapy obsolete,” Dudek told Asbestos.com. “People can be really excited about this one.” He based his optimism on the pote...
Source: Asbestos and Mesothelioma News - June 1, 2018 Category: Environmental Health Authors: Walter Pacheco Source Type: news

Medical News Today: Sandalwood scent may tackle bladder cancer tumors
New research has identified olfactory receptors in cancerous bladder tissue. These could make good biomarkers, and they may also help to improve therapy. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 1, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

EMA recommends restrictions on Merck, Roche immunotherapies
ZURICH (Reuters) - The European Medicines Agency on Friday recommended restricting use of two immunotherapies, one from Roche and the other from Merck, in initial bladder cancer treatment, saying they may not work as well as chemotherapy in some patients. (Source: Reuters: Health)
Source: Reuters: Health - June 1, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: What to expect with bladder removal surgery
Bladder removal surgery or cystectomy is a procedure to remove the urinary bladder. It is commonly used to treat bladder cancer or other pelvic tumors. A person should go into surgery knowing what to expect, during and after the procedure, including recovery times, outlook, and the effect on quality of life afterward. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 31, 2018 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Prostate cancer warning - add this 18p fruit to your diet to slash your risk
PROSTATE cancer symptoms include passing more urine than normal, rushing to the toilet, and feeling like your bladder is never truly empty. But, adding this cheap fruit to your diet could lower your risk of the deadly tumour, which is the most commonly diagnosed male cancer in the UK. (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2018 Category: Consumer Health News Source Type: news

Bladder cancer symptoms: Seeing THIS in your urine could be a sign of the dangerous cancer
BLADDER cancer symptoms appear when a tumour develops in the lining of this organ. You are more at risk of bladder cancer if you ’re a smoker, or have been exposed to certain chemicals through your profession, such as in the plastics, paints and textiles industries. Finding this in your urine could be a sign of the dangerous cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2018 Category: Consumer Health News Source Type: news

Bladder cancer symptoms: Finding THIS in your urine could be a sign you have the cancer
BLADDER cancer symptoms appear when a tumour develops in the lining of this organ. You are more at risk of bladder cancer if you ’re a smoker, or have been exposed to certain chemicals through your profession, such as in the plastics, paints and textiles industries. Finding this in your urine could be a sign of the dangerous cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2018 Category: Consumer Health News Source Type: news

Urologists Practice Spotting Tumors With Virtual Reality Technology
BOSTON (CBS) – Virtual reality is being used in healthcare more, and a local company is using the technology to help doctors identify hard-to-see tumors in the bladder. Almost 80,000 Americans are diagnosed with bladder cancer every year. To find bladder tumors, a urologist looks directly at the inside of the bladder using a cystoscope, a small tube with a camera and light attached. Cystoscopes are equipped with technology called narrow band imaging. (WBZ-TV) Some tumors are harder to find. But to make it easier, many cystoscopes are equipped with technology called narrow band imaging (NBI). “What NBI does is i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 29, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall HealthWatch Local TV Virtual Reality Source Type: news

Olfactory receptor as therapeutic target in bladder cancer
(Ruhr-University Bochum) Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis. Using cell culture studies, the team headed by Professor Dr. Hanns Hatt and Dr. Lea Weber demonstrated that the receptor occurs more frequently in bladder cancer tissue than in healthy bladder tissue. Accordingly, significant higher amounts of the receptor could be found in the urine samples of patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 29, 2018 Category: Cancer & Oncology Source Type: news

CR Rate of 30% With Agent for High-Risk Bladder Cancer CR Rate of 30% With Agent for High-Risk Bladder Cancer
With a complete response (CR) rate of 30%, the experimental agent CG0070 is in a race to be the first drug since 1998 for the treatment of BCG-unresponsive bladder cancer.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Living With Cancer: Understanding bladder cancer
Bladder cancer? Bladder cancer is one of the most common cancers, affecting approximately 68,000 adults in the U.S. each year. Bladder cancer occurs more frequently in men and usually affects older adults. May is Bladder Cancer Awareness Month, which makes it a good time to learn more about the symptoms, causes, risk factors and treatment [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 25, 2018 Category: Databases & Libraries Source Type: news

Staff shortages a factor in case where patient died due to delays
Staffing shortages at a hospital run by Barking, Havering and Redbridge University Hospitals NHS Trust were a factor in the case of a grandmother whose “painful” death from bladder cancer could have been avoided, a report by the health service ombudsman has revealed. (Source: Nursing Times)
Source: Nursing Times - May 22, 2018 Category: Nursing Source Type: news

Bladder cancer symptoms: Three toilet habits that could indicate you have the disease
BLADDER cancer symptoms usually involve having blood in your urine, but there are some other, less common signs of the disease to look out for, all linked to urination and your toilet habits. (Source: Daily Express - Health)
Source: Daily Express - Health - May 22, 2018 Category: Consumer Health News Source Type: news

Grandmother died after NHS doctors failed to detect bladder cancer  
Pamela North was referred to hospital by her GP with suspected bladder cancer in February 2015. The grandmother from Ilford, Essex, was diagnosed a year later but died in 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - May 22, 2018 Category: Consumer Health News Source Type: news

Bladder cancer model could pave the way for better drug efficacy studies
(UNC Lineberger Comprehensive Cancer Center) In the journal Cancer Research, UNC Lineberger Comprehensive Cancer Center researchers report they have developed a model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to checkpoint inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 21, 2018 Category: Cancer & Oncology Source Type: news

Karl Storz Focuses on Bladder Cancer Detection With New Device
Karl Storz is focusing on bladder cancer detection with its latest product. The El Segunda, CA-based company said it is launching the PDD Blue Light Flexible Video Cytoscopy System. The product launch follows the approval of a supplemental new drug application and a premarket approval supplement from FDA extending the indication for Blue Light Cystoscopy with Cysview (BLCC) to include use of the new Karl Storz PDD Blue Light Flexible Video Cystoscope. Also included in the approval is an expanded indication for the repetitive use of Cysview within the same patient and for the identification of Carcinoma in Situ (CIS); one o...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
OSLO, Norway, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), May 16, 2018, announced today the launch of Blue Light Cystoscopy (BLC™) with Cysview for a new indication of surveillance cystoscopy of bladder cancer. ... Devices, Diagnostics, Oncology, Product Launch Photocure, Karl Storz, Blue Light Cystoscopy, Cysview, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

PPD Skin Test Enhances Bacillus Calmette-Gu & eacute;rin Tx in Bladder CA
WEDNESDAY, May 16, 2018 -- For patients with non-muscle invasive bladder cancer, undergoing the purified protein derivative skin test prior to bacillus Calmette-Gu érin therapy may have therapeutic impact, according to a study published in the June... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Genetic fixer-uppers may help predict bladder cancer prognosis
(Penn State) Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers, who found that bladder cancer patients who had mutations in their ATM or RB1 genes -- proteins that help repair DNA damage when they're functioning normally -- tended not to live as long as patients without the mutations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 15, 2018 Category: Cancer & Oncology Source Type: news

Single Gemcitabine Instillation Can Reduce Urothelial Cancer Recurrence
An intravesical instillation of gemcitabine following TURBT reduced the risk of recurrence in patients with suspected low-grade non –muscle-invasive urothelial cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 14, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers SiteTerms/www.cannabissciencetech.com/News Source Type: news

Dose-Dense Chemo Shows Promise as Neoadjuvant Therapy in Bladder Cancer
A neoadjuvant dose-dense regimen was active and well tolerated in patients with muscle-invasive bladder cancer, allowing downstaging of most patients before radical cystectomy. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers SiteTerms/www.cannabissciencetech.com/News Source Type: news

Simple Post-Surgery Step Reduces Bladder Cancer Recurrence
Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study led by Edward M. Messing, M.D., and an international clinical trials network funded by the National Cancer Institute. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - May 9, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence
TUESDAY, May 8, 2018 -- Immediate post-resection intravesical installation of gemcitabine is associated with reduced recurrence over four years for patients with suspected low-grade non-muscle-invasive urothelial cancer, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Simple post-surgery step reduces bladder cancer recurrence
(SWOG) In the latest issue of JAMA, SWOG researchers show that flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Prostate Cancer: Eating these everyday foods could increase your risk
PROSTATE cancer symptoms include pain while seeing, loss of bladder control and more frequent urges to urinate at night. You are at greater risk of developing the condition if you are 65 or over, overweight or have a family history of the condition, among other factors. Prostate Cancer UK recommends avoiding these foods to cut your prostate cancer risk. (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2018 Category: Consumer Health News Source Type: news

Bladder Cancer
Title: Bladder CancerCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/1/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 1, 2018 Category: Cancer & Oncology Source Type: news

Boston Scientific closes $400m NxThera buy
Boston Scientific (NYSE:BSX) said today that closed the $406 million acquisition of NxThera and its Rezūm benign prostatic hyperplasia device, which uses steam to ablate excess prostate tissue. The deal called for $306 million in up-front cash from Marlborough, Mass.-based Boston Scientific, with another $100 million in potential milestones over the next four years. Boston, which in December 2015 led a $40 million funding round for NxThera, said the existing investment means it will have to put $240 million down and another $85 million on the table in milestones. NxThera is based in ...
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Wall Street Beat Boston Scientific NxThera Inc. Source Type: news

A study links soil metals with cancer mortality
(FECYT - Spanish Foundation for Science and Technology) Spanish epidemiologists and geologists have found associations between esophageal cancer and soils where lead is abundant, lung cancer and terrains with increased copper content, brain tumor with areas rich in arsenic, and bladder cancer with high cadmium levels. These statistical links do not indicate that there is a cause-effect relationship between soil type and cancer, but they suggest that the influence of metals from the earth's surface on the geographical distribution of tumors should be analyzed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 20, 2018 Category: Cancer & Oncology Source Type: news

The Next Generation of Surgeon Investigators: Surgical Trainees Answer Tough Questions Facing Surgeons and Patients
How do we define “competence” in surgical consultation? What factors lead to overuse of invasive screening tests in low-risk patients with bladder cancer? These were some of the questions asked by the fifteen young surgical investigators from the Geisel School of Medicine and Dartmouth-Hitchcock Medical Center at the sixth annual STARS (Surgical Trainees Advancing Research Symposium) event on April 12-13. Sponsored by the Department of Surgery, the two-day event promotes interest in surgical health services research among young and aspiring surgeons through a spirited but supportive competition. (Source: News a...
Source: News at Dartmouth Medical School - April 18, 2018 Category: Hospital Management Authors: Geisel Communications Tags: Education Insider News event med students research surgery trainees Source Type: news

Neoadjuvant Anti-PD-1 Active in Multiple Tumors (CME/CE)
(MedPage Today) -- Major responses in pilot study for NSCLC, melanoma, bladder cancers (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 18, 2018 Category: Dermatology Source Type: news

Systemic Therapy for Advanced Bladder Cancer Evolves
Dr. Elizabeth Plimack discusses her 2018 AACR meeting presentation on recent advances in systemic therapy for bladder cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 11, 2018 Category: Cancer & Oncology Authors: Elizabeth Plimack, MD Tags: Conferences/AACR Street Team Bladder Cancer Genitourinary Cancers News Source Type: news

Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
WEDNESDAY, April 11, 2018 -- Gemcitabine and cisplatin (GC) plus ipilimumab is associated with a 69 percent objective response rate and 61 percent one-year overall survival for patients with metastatic urothelial cancer, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2018 Category: Pharmaceuticals Source Type: news

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumors have certain genetic mutations may respond particularly well to this combination approach, according to the results of a clinical trial published in European Urology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 11, 2018 Category: Cancer & Oncology Source Type: news

Pembrolizumab Offers Better QOL vs Chemo in Advanced Urothelial Cancer
Pembrolizumab offered stable or improved measures of global health status and quality of life compared with chemotherapy in patients with previously treated advanced urothelial cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 9, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers SiteTerms/www.cannabissciencetech.com/News Source Type: news

Organoids from bladder cancer could help doctors treat disease
Organoids derived from a patient's bladder cancer cells hold promise for future treatment of the disease, according to researchers in a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 6, 2018 Category: Consumer Health News Source Type: news

Organoids created from patients' bladder cancers could guide treatment
(Columbia University Medical Center) Researchers have created patient-specific bladder cancer organoids that mimic many of the characteristics of actual tumors. The use of organoids, tiny 3-D spheres derived from a patient's own tumor, may be useful in the future to guide treatment of patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2018 Category: International Medicine & Public Health Source Type: news

Mesothelioma Clinical Trial Opens with Optimism in South Florida
Dr. Chukwuemeka Ikpeazu at the Sylvester Comprehensive Cancer Center has brought hope — where once there was none — to patients in South Florida with unresectable pleural mesothelioma. Ikpeazu is the principal investigator in the multicenter phase II clinical trial involving the much-anticipated immunotherapy drug durvalumab. Pharmaceutical giant AstraZeneca manufactures the drug under the brand name Imfinzi. “I am optimistic, very, very optimistic that this drug will be effective for these patients,” Ikpeazu told Asbestos.com. “All the data, all the earlier studies, are encouraging.” He...
Source: Asbestos and Mesothelioma News - April 4, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Enfortumab Vedotin Granted Breakthrough Designation for Metastatic Bladder Cancer
The FDA has granted a Breakthrough Therapy designation to the antibody-drug conjugate enfortumab vedotin for patients with locally advanced or metastatic urothelial cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 3, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers SiteTerms/www.cannabissciencetech.com/News Source Type: news

Cytoreduction, Metastasis-Directed Therapy in Bladder Cancer Cytoreduction, Metastasis-Directed Therapy in Bladder Cancer
Cytoreduction and metastasis-directed therapy have shown promise in several types of solid tumors, but could it also benefit patients with urothelial bladder cancer?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 29, 2018 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Prostate cancer symptoms: This nighttime habit could indicate you have the disease
PROSTATE cancer symptoms have a lot to do with your toilet habits. Difficulty in starting to pee and feeling your bladder has not emptied fully are just a couple of the signs. One particular nighttime habit could also indicate you have the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - March 23, 2018 Category: Consumer Health News Source Type: news

Gene-based test for urine detects, monitors bladder cancer
(Johns Hopkins Medicine) Researchers at The Johns Hopkins Kimmel Cancer Center have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

UPDATE: Boston Scientific lays out $406m for NxThera which plans spin-out of cancer treatment tech
Updated to include commentary from NxThera prez & CEO Bob Paulson. Boston Scientific (NYSE:BSX) said today that it laid out a $406 million deal for NxThera and its Rezūm benign prostatic hyperplasia device, which uses steam to ablate excess prostate tissue. The deal calls for $306 million in up-front cash from Marlborough, Mass.-based Boston Scientific, with another $100 million in potential milestones over the next four years. Boston, which in December 2015 led a $40 million funding round for NxThera, said the existing investment means it will have to put $240 million down and another $8...
Source: Mass Device - March 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Wall Street Beat Boston Scientific NxThera Inc. Source Type: news

Differential Methylation in CITED4: Bladder Cancer Risk Biomarker?
Differential methylation in CITED4, as measured in blood, appears to be a promising marker of bladder cancer susceptibility in women. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Anne Landry Tags: Bladder Cancer News Source Type: news

Response and Development of Immune-Related Adverse Events in an 83-Year-Old Man With Metastatic Urothelial Cancer
An 83-year-old man was diagnosed with multiple low-grade transitional cell carcinomas over a 6-year period. A surveillance cystoscopy in year 7 showed high-grade noninvasive papillary urothelial carcinoma in the bladder trigone. A CT urogram showed a soft-tissue mass with diffuse enhancement in the lower pole of the left kidney, concerning for malignancy. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Daniel P. Petrylak, MD Karishma K. Mehra, MD Tags: Bladder Cancer Genitourinary Cancers Oncology Journal Source Type: news

DDR Alterations Signal Immunotherapy Benefit in Urothelial Carcinoma
Alterations to DDR genes were associated with improved outcomes in patients with metastatic urothelial carcinoma who were treated with immunotherapy. (Source: CancerNetwork)
Source: CancerNetwork - March 8, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers News Source Type: news

Diet and exercise prevents diabetes in dogs too: Canine obesity is on the rise, along with all the related health problems
(Natural News) Research shows that overweight and obese dogs suffer from a host of health problems like musculoskeletal disorders, cardiovascular diseases, glucose intolerance, diabetes, and bladder and mammary cancer. A high-fat diet, which leads to excess weight and obesity, was also linked to canine pancreatitis, which is characterized by appetite loss and vomiting. Science has... (Source: NaturalNews.com)
Source: NaturalNews.com - March 8, 2018 Category: Consumer Health News Source Type: news

Evaluating Two RT-Plus-Chemotherapy Strategies in Bladder Cancer Patients Undergoing Bladder Surgery
In this interview, we spoke with John J. Coen, MD, a radiation oncologist who presented results at the 2018 Genitourinary Cancers Symposium of a phase II study exploring two different radiation-plus-chemotherapy combination strategies in patients undergoing bladder surgery for their tumors. (Source: CancerNetwork)
Source: CancerNetwork - March 7, 2018 Category: Cancer & Oncology Authors: John J. Coen, MD Tags: Conferences/ASCO Genitourinary Cancers Symposium Bladder Cancer News Source Type: news

Prostate cancer symptoms - Eat more of this 18p fruit to slash your risk of disease
PROSTATE cancer symptoms include having a burning sensation when urinating, and losing control of the bladder. You could prevent the disease by adding this cheap fruit to your diet. (Source: Daily Express - Health)
Source: Daily Express - Health - March 7, 2018 Category: Consumer Health News Source Type: news

This Couple Died By Assisted Suicide Together. Here ’s Their Story
On the last morning of their lives, Charlie and Francie Emerick held hands. The Portland, Ore., couple, married for 66 years and both terminally ill, died together in their bed April 20, 2017, after taking lethal doses of medication obtained under the state’s Death with Dignity law. Francie, 88, went first, within 15 minutes, a testament to the state of her badly weakened heart. Charlie, 87, a respected ear, nose and throat (ENT) physician, died an hour later, ending a long struggle that included prostate cancer and Parkinson’s disease diagnosed in 2012. “They had no regrets, no unfinished business,&rdquo...
Source: TIME: Health - March 6, 2018 Category: Consumer Health News Authors: JoNel Aleccia / Kaiser Health News Tags: Uncategorized Dying healthytime Source Type: news

Prostate cancer: Presenter Bill Turnbull diagnosed with disease - symptoms to look out for
PROSTATE cancer symptoms include frequent urination and feeling like your bladder is never truly empty. Former BBC Breakfast presenter Bill Turnbull has revealed his prostate cancer diagnosis, and wants other men to get tested, too. These are the signs to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - March 6, 2018 Category: Consumer Health News Source Type: news